Adamas Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ADMS and buy or sell other stocks, options, and ETFs commission-free!

About ADMS

Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. 

CEO
Neil F. McFarlane
CEONeil F. McFarlane
Employees
Employees
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
2000
Founded2000
Employees
Employees

ADMS Key Statistics

Market cap
376.37M
Market cap376.37M
Price-Earnings ratio
-4.85
Price-Earnings ratio-4.85
Dividend yield
Dividend yield
Average volume
964.73K
Average volume964.73K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$9.15
52 Week high$9.15
52 Week low
$4.02
52 Week low$4.02
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.